Trending
Recently Published
All Articles
Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'30.11.2025An Israel Democracy Institute expert warns that MK Boaz Bismuth’s haredi draft offers no real enforcement and will not improve enlistment rates. Nothing will change from MK Boaz Bismuth’s (Likud) bill to enforce haredi (ultra-Orthodox) conscription to the IDF, which is currently being advanced merely for the government, “to stall for time,” Shlomit Ravitsky Tur-Paz of the Israel Democracy Institute told The Jerusalem Post on Sunday.
Palestinian leader Abbas says elections only after Gaza war ends13.12.2025Longtime Palestinian President Mahmoud Abbas has dampened hopes for elections that are years overdue. Presidential and parliamentary polls should be held within a year after the end of the Gaza war, Abbas said on Friday in Rome, according to the Palestinian news agency WAFA.
Vote in favor of your Favored Kind of Scarf07.11.2023Scarves are a flexible embellishment that can upgrade any outfit while giving warmth and style. Accessible in different materials, designs,
Affordable Care Act enrollment is slightly ahead of last year, despite expiring subsidies08.12.2025The number of Americans signing up for Affordable Care Act health insurance for 2026 is moderately higher than it was at a similar time last year, initial new federal data shows, even as subsidies set to expire at the end of 2025 will make the coverage more expensive for many. “Overall, it’s just too early to know what any of this means,” said Jason Levitis, a senior fellow in the health policy division at the Urban Institute. The data released Friday shows that by day 29 of the window for Ame
Manual for Famous Beverages 202405.06.2024Finding different delectable and reviving refreshments can raise your day to day hydration normal and proposition remarkable medical advantages. Green
Baby takes 1st steps after receiving groundbreaking gene-edited therapy18.12.2025KJ Muldoon received a groundbreaking new treatment earlier this year.
Novo and Lilly cut prices of weight-loss drugs in China30.12.2025Dec 29 () - Novo Nordisk and Eli Lilly are lowering prices of their top-selling obesity drugs Wegovy and Mounjaro in China, according to the Danish drugmaker and Chinese drug suppliers. Novo did not give details on the new prices, but media outlet Yicai reported earlier that list prices for the two highest dosages of Wegovy were cut by 48% to 987 yuan ($141) and 1,284 yuan per month respectively in some Chinese provinces.
Figure out How to Remain Informed about the Most recent Open Record Extra Offers19.10.2023Remaining informed about the new open record extra offers is pivotal for anybody hoping to expand their investment funds and make













